OPTION TO PURCHASE SENIOR CONVERTIBLE NOTEOption to Purchase Senior Convertible Note • January 11th, 2019 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
This option is granted and effective as of January 7, 2019 (the “Effective Date”) by and between Gustavia Capital Partners LLC and/or its affiliates, the holders of the Senior Convertible Note originally issued to Gustavia Capital Partners LLC (collectively, “Holder”) and Innovate Biopharmaceuticals, Inc., a Delaware corporation (“INNT” or the “Company”).
